Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Nuwellis, Inc. stock logo
CHFS
Nuwellis
$0.20
-10.6%
$4.79
$4.86
$37.50
$1.19M1.55467,323 shs2.25 million shs
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$1.03
-5.5%
$1.01
$0.71
$1.61
$64.49M1.19149,288 shs118,178 shs
Modular Medical, Inc. stock logo
MODD
Modular Medical
$0.73
-0.2%
$0.87
$0.63
$2.65
$39.53M0.17220,083 shs67,478 shs
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$1.95
-0.5%
$2.14
$1.72
$5.35
$6.26M0.9316,915 shs6,437 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Nuwellis, Inc. stock logo
CHFS
Nuwellis
0.00%-17.42%-67.95%-79.55%-95.12%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
0.00%-15.45%-1.89%+5.00%+14.42%
Modular Medical, Inc. stock logo
MODD
Modular Medical
0.00%+7.38%-13.63%-8.88%-51.07%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
0.00%-3.47%-8.45%-2.01%-51.25%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Nuwellis, Inc. stock logo
CHFS
Nuwellis
N/AN/AN/AN/AN/AN/AN/AN/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
1.952 of 5 stars
3.52.00.00.02.30.00.6
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.5957 of 5 stars
3.55.00.00.00.01.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Nuwellis, Inc. stock logo
CHFS
Nuwellis
0.00
N/AN/AN/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
3.00
Buy$5.50433.98% Upside
Modular Medical, Inc. stock logo
MODD
Modular Medical
0.00
N/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.00
Buy$5.00156.41% Upside

Current Analyst Ratings Breakdown

Latest STRR, CHFS, CTSO, and MODD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/25/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
5/15/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
5/15/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$1.00 ➝ $1.00
5/15/2025
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$8.00 ➝ $5.00
5/2/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Nuwellis, Inc. stock logo
CHFS
Nuwellis
$5.51M0.22N/AN/A$12.79 per share0.02
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$35.60M1.81N/AN/A$0.20 per share5.15
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/AN/AN/AN/A$0.42 per shareN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$53.36M0.12$0.32 per share6.01$10.98 per share0.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Nuwellis, Inc. stock logo
CHFS
Nuwellis
-$18.11M-$279.28N/AN/AN/A-254.26%-173.61%-131.01%N/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$20.72M-$0.28N/AN/AN/A-41.77%-105.04%-29.18%8/12/2025 (Estimated)
Modular Medical, Inc. stock logo
MODD
Modular Medical
-$18.82M-$0.51N/AN/AN/A-178.13%-151.42%8/12/2025 (Estimated)
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$10.44M-$3.43N/AN/AN/A-16.43%-8.24%-3.48%8/12/2025 (Estimated)

Latest STRR, CHFS, CTSO, and MODD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/20/2025Q4 2025
Modular Medical, Inc. stock logo
MODD
Modular Medical
-$0.11-$0.12-$0.01-$0.12N/AN/A
5/14/2025Q1 2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$0.08-$0.06+$0.02-$0.02$9.01 million$8.73 million
5/14/2025Q1 2025
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$0.25-$0.52-$0.27-$0.37$16.35 million$12.92 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Nuwellis, Inc. stock logo
CHFS
Nuwellis
N/AN/AN/AN/AN/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
N/AN/AN/AN/AN/A
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Nuwellis, Inc. stock logo
CHFS
Nuwellis
N/A
6.87
5.97
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
0.98
2.61
2.30
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/A
10.69
10.69
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
0.22
1.42
0.88

Institutional Ownership

CompanyInstitutional Ownership
Nuwellis, Inc. stock logo
CHFS
Nuwellis
65.06%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
32.87%
Modular Medical, Inc. stock logo
MODD
Modular Medical
27.47%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.84%

Insider Ownership

CompanyInsider Ownership
Nuwellis, Inc. stock logo
CHFS
Nuwellis
0.60%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
6.60%
Modular Medical, Inc. stock logo
MODD
Modular Medical
20.46%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
33.51%
CompanyEmployeesShares OutstandingFree FloatOptionable
Nuwellis, Inc. stock logo
CHFS
Nuwellis
666.04 millionN/ANot Optionable
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
22062.61 million58.48 millionOptionable
Modular Medical, Inc. stock logo
MODD
Modular Medical
2054.25 million43.15 millionNot Optionable
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
4603.21 million2.13 millionNot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Nuwellis stock logo

Nuwellis NASDAQ:CHFS

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Cytosorbents stock logo

Cytosorbents NASDAQ:CTSO

$1.03 -0.06 (-5.50%)
As of 04:00 PM Eastern

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Modular Medical stock logo

Modular Medical NASDAQ:MODD

$0.73 0.00 (-0.22%)
As of 04:00 PM Eastern

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.

Star Equity stock logo

Star Equity NASDAQ:STRR

$1.95 -0.01 (-0.51%)
As of 03:43 PM Eastern

Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.